Science Explorer Back to mapMap
Discussion
Topic · Cardiology and Cardiovascular Medicine

Cardiac tumors and thrombi

Cardiac tumors and thrombi is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 29k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, management, and molecular features of cardiac tumors, including primary cardiac neoplasms, left ventricular thrombus, and pulmonary artery sarcoma. It also explores the genetic mutations associated with conditions like the Carney complex and PRKAR1A gene mutations. The papers discuss imaging techniques such as echocardiography and MRI for evaluating cardiac masses and tumors.

  • Cardiac Tumors
  • PRKAR1A Gene Mutations
  • Left Ventricular Thrombus
  • Cardiac Imaging
  • Primary Cardiac Neoplasms
  • Carney Complex
  • Pulmonary Artery Sarcoma
  • Echocardiography
  • Metastatic Cardiac Involvement
  • Cardiac Myxomas
Research works
29k
fractional, since 1950
In the world top 10%
2.9k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+16%
the tick is no change
Largest producer
United States
37% of the 10 largest, 2022-now
Cardiac tumors and thrombi

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cardiac tumors and thrombi research?

By volume, the United States and China publish the most (1.6k and 864 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.6k works
  2. 2 China 864 works
  3. 3 Japan 521 works
  4. 4 India 376 works
  5. 5 Italy 271 works
  6. 6 United Kingdom 175 works
  7. 7 Spain 171 works
  8. 8 Germany 169 works
  9. 9 France 134 works
  10. 10 Türkiye 119 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 37.0%China: 19.4%Japan: 11.7%India: 8.5%6 others listed: 23.4%37%largest
United States1,645 · 37.0%China864 · 19.4%Japan521 · 11.7%India376 · 8.5%6 others listed1,039 · 23.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cardiac tumors and thrombi research?

By volume in 2022-now, Mayo Clinic publishes the most Cardiac tumors and thrombi research, followed by All India Institute of Medical Sciences and Harvard University.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 68 works
  2. 2 All India Institute of Medical SciencesIndia 49 works
  3. 3 Harvard UniversityUnited States 46 works
  4. 4 Sichuan UniversityChina 42 works
  5. 5 Cleveland ClinicUnited States 42 works
  6. 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 34 works
  7. 7 Peking UniversityChina 30 works
  8. 8 Capital Medical UniversityChina 29 works
  9. 9 Zhejiang UniversityChina 24 works
  10. 10 The University of Texas MD Anderson Cancer CenterUnited States 24 works

Who are the leading researchers in Cardiac tumors and thrombi?

The most-cited researchers publishing on Cardiac tumors and thrombi include John J.V. McMurray, Stephan Windecker and Graeme J. Hankey.

  1. 1 John J.V. McMurray United Kingdom 349k citations
  2. 2 Stephan Windecker Switzerland 338k citations
  3. 3 Graeme J. Hankey Australia 316k citations
  4. 4 Gregory Y.H. Lip United Kingdom 311k citations
  5. 5 Salim Yusuf Canada 294k citations
  6. 6 Todd R. Golub United States 283k citations
  7. 7 Hagop M. Kantarjian United States 273k citations
  8. 8 Patrick M. Bossuyt Netherlands 270k citations
  9. 9 Victoria Delgado Netherlands 269k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cardiac tumors and thrombi?

The most cited paper in Cardiac tumors and thrombi is "Pathology of the Vulnerable Plaque" (Renu Virmani, ALLEN P. BURKE, Andrew A. Farb et al., 2006), with 2,326 citations. Next come "Hypoxia in cancer: significance and impact on clinical outcome" (2,256) and "Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart" (1,926).

Most cited papers
#PaperReleasedCitations
1 Pathology of the Vulnerable Plaque Renu Virmani, ALLEN P. BURKE, Andrew A. Farb et al. · Journal of the American College of Cardiology Open access Apr 2006 2,326
2 Hypoxia in cancer: significance and impact on clinical outcome Peter W. Vaupel, Arnulf Mayer · Cancer and Metastasis Reviews Review 18 Apr 2007 2,256
3 Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart William David Travis, Elisabeth M. Brambilla, ALLEN P. BURKE et al. · Journal of Thoracic Oncology Open access 21 Aug 2015 1,926
4 Clinical classification of pulmonary hypertension Gérald Simonneau, Nazzareno Galiè, Lewis J. Rubin et al. · Journal of the American College of Cardiology Open access Jun 2004 1,906
5 Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Paolo Prandoni, Anthonie W.A. Lensing, Andrea Piccioli et al. · Blood Open access 30 Oct 2002 1,868
All 100 most cited papers, with filters and sorting

Where is Cardiac tumors and thrombi research done?

The largest centres of Cardiac tumors and thrombi research in 2022-now are Beijing (China), Tokyo (Japan), New York (United States) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Scottsdale.

Largest cities, 2022-now

  1. 1 BeijingChina 137 works
  2. 2 TokyoJapan 95 works
  3. 3 New YorkUnited States 73 works
  4. 4 LondonUnited Kingdom 57 works
  5. 5 ShanghaiChina 57 works
  6. 6 ClevelandUnited States 56 works
  7. 7 ChengduChina 55 works
  8. 8 New DelhiIndia 54 works
  9. 9 HoustonUnited States 53 works
  10. 10 MadridSpain 50 works

Where it is the local speciality

  1. ScottsdaleUS · 32.0 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cardiac tumors and thrombi than the world average.

See Cardiac tumors and thrombi on the map

Where is the best place to study Cardiac tumors and thrombi?

Among universities, judged by research, Harvard University, University of Ottawa and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.52%fractional works in this field (log) →share of work in the world top 10% →University of OttawaJohns Hopkins Univer…Harvard UniversityChinese Academy of M…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 73.619.2%2.7×46 -12.6%
2University of OttawaCanada 67.337.4%3.2×12 +66.1%
3Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 62.314.8%6.1×34 +33.4%
4Johns Hopkins UniversityUnited States 61.122.1%2.0×16 +30.5%
5Fujian Medical UniversityChina 58.428.7%4.0×12 +25.6%
6Peking UniversityChina 57.614.5%2.8×30 +65.2%
7Sichuan UniversityChina 56.910.9%3.5×42 +26.7%
8University of California, Los AngelesUnited States 55.812.5%3.5×22 +25.5%
9University of TorontoCanada 55.421.2%1.4×16 +6.0%
10University of MiamiUnited States 54.513.9%5.8×19 +24.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cardiac tumors and thrombi, country by country

Is Cardiac tumors and thrombi research growing?

Output in 2022-2025 was 16% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cardiac tumors and thrombi.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cardiac tumors and thrombi as a percentage of every work published that year, 0.025% in 2024.

still counting0.020%0.040%Cardiac tumors and thrombi0.026% in 202519801990200020102020

Fractional works of Cardiac tumors and thrombi over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cardiac tumors and thrombi10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cardiac tumors and thrombi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.